Cancer Consult: Expertise in Clinical Practice, Volume 1
Solid Tumors & Supportive Care
2. Edition December 2023
752 Pages, Softcover
Practical Approach Book
CANCER CONSULT
New edition covering the specialties of hematology, oncology and cellular therapy, now in two volumes
Cancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors & Supportive Care, Second Edition includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book's smaller size allows for easy access during medical rounds. This volume also includes:
* Up-to-date, clinically relevant information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, cellular therapy and translational cancer research
* Sections on head, neck, thoracic, breast, GI, genitourinary, skin, gynecological and hereditary cancers, amongst other topics
* Streamlined, engaging content to make finding information easier and less time consuming for the reader
* Concise and practical expert perspectives that reference key studies
* References to the latest NCCN, ESMO, ASCO, and other national guidelines
With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, Cancer Consult: Expertise in Clinical Practice, Volume 1: Solid Tumors & Supportive Care, Second Edition will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM, hematology and oncology fellowship and recertification exams.
Volume 2: Neoplastic Hematology & Cellular Therapy
Editors xii
Editor's Biography xiii
Preface xv
Acknowledgment xvii
Part 1 Central Nervous System 1
1 Central Nervous System Tumors 3
Mark R. Gilbert and Edina Komlodi-Pasztor
Part 2 Head and Neck and Thoracic Cancers 13
2 Localized Head and Neck Cancer 15
Emrullah Yilmaz and Jessica L. Geiger
3 Recurrent and Metastatic Head and Neck Cancer 31
Chloe Weidenbaum and Mike Gibson
4 Thyroid Cancers 39
Kartik Sehgal and Jochen H. Lorch
5 Non-Small Cell Lung Cancer: Screening, Staging, and Stage I 51
Ryan D. Gentzler and Linda W. Martin
6 Non-Small Cell Lung Cancer: Stages II and III 63
Gregory Peter Kalemkerian, Kamya Sankar, and Angel Qin
7 Recurrent and Metastatic Non-Small Cell Lung Cancer 79
Julia Judd, J. Nicholas Bodor, and Hossein Borghaei
8 Small Cell Lung Cancer 97
Jyoti D. Patel and Husam Hafzah
9 Mesothelioma 105
Harvey I. Pass, David Chen, and Jack Donaghue
Part 3 Breast Cancer 115
10 DCIS and LCIS 117
Amanda Nash, Rita Mukhtar, and Shelley Hwang
11 Early-Stage ER/PR -Positive, HER2-Negative Breast Cancer 129
William J. Gradishar
12 ER/PR-Positive, HER2-Negative Metastatic Breast Cancer 139
Sara Nunnery, Laura Kennedy, and Sonya Reid
13 Early-Stage HER2-Positive Breast Cancer 151
Erin Roesch and Jame Abraham
14 HER2-Positive Metastatic Breast Cancer 163
Reshma L. Mahtani, Naomi G. Dempsey, and Ana Sandoval
15 Early-Stage Triple-Negative Breast Cancer 179
Tiffany A. Traina, Carlos dos Anjos, and Elaine Walsh
16 Triple-Negative Metastatic Breast Cancer 191
Azadeh Nasrazadani, Juan Gomez, and Adam Brufsky
17 Inflammatory Breast Cancer - A Distinct Entity 201
Massimo Cristofanilli and Elena Vagia
18 Male Breast Cancer 213
Laura A. Huppert, Ozge Gumusay, Shreya Desai, and Hope S. Rugo
19 Breast Cancer in Pregnancy and Fertility Preservation 225
Fedro A. Peccatori, Hatem Azim, and Matteo Lambertini
Part 4 Gastrointestinal Cancers 233
20 Early-Stage Gastroesophageal Cancer and Precursor Lesions 235
Yixing Jiang and Aaron Ciner
21 Metastatic Esophagogastric Cancer 249
Geoffrey Y. Ku and David H. Ilson
22 Early-Stage Colon Cancer 255
John Krauss, Vaibhav Sahai, and Al B. Benson III
23 Early-Stage Rectal Cancer 267
Hannah J. Roberts, Theodore Hong, and Aparna Parikh
24 Recurrent and Metastatic Colorectal Cancer 283
Joseph Heng and Blase Polite
25 Pancreatic Adenocarcinoma 291
Evan Walker, Andrew Ko, and Margaret Tempero
26 Hepatocellular Cancer 309
Pedro Luiz Serrano Uson Junior and Mitesh Borad
27 Biliary Tract Cancers 319
David B. Zhen and Vaibhav Sahai 28 Carcinoid and Neuroendocrine Tumors 327
Mintallah Haider and Jonathan Strosberg
29 Anal Cancer 343
Asad Mahmood and Rob Glynne-Jones
Part 5 Genitourinary Cancers 359
30 Renal Cancer 361
James L. Coggan, Alan Tan, and Timothy M. Kuzel
31 Bladder Cancer 375
Revathi Kollipara, Alan Tan, and Timothy M. Kuzel
32 Prostate Cancer: Screening, Surveillance, Prognostic Algorithms, and Independent Pathologic Predictive Parameters 389
Eduardo Benzi and Thomas M. Wheeler
33 Early and Locally Advanced Prostate Cancer 399
James Randall, Mohammad R. Siddiqui, Ashley Ross, and Sean Sachdev
34 Metastatic Prostate Cancer 421
Priyanka Chablani, Natalie Reizine, and Walter Stadler
35 Germ Cell Tumors 437
Hamid Emamekhoo, Syed A. Abutalib, and Timothy Gilligan
Part 6 Skin Malignancies 453
36 Melanoma 455
Ana M. Ciurea and Kim Margolin
37 Nonmelanoma Skin Cancers 477
Chrysalyne D. Schmults and Danielle A. Parker
Part 7 Gynecological Cancers 497
38 Ovarian Cancer: Primary Treatment and Approach to Recurrent Disease 499
Rani Bansal, Don Dizon, and Martina Murphy
39 Ovarian Cancer: Second-line Treatment Strategies 511
Maurie Markman
40 Endometrial Cancer 523
Maurie Markman
41 Cancer of the Cervix, Vulva, and Vagina 533
Sabrina M. Bedell and Peter G. Rose
42 Uncommon Gynecologic Cancers 549
Michael Frumovitz, Shannon Westin, and David M. Gershenson
Part 8 Sarcomas 565
43 Bone Sarcomas 567
Nicole Larrier, William Eward, and Richard F. Riedel
44 Soft Tissue Sarcomas 579
Jeffrey Farma, Krisha Howell, and Margaret von Mehren
Part 9 Hereditary Cancer Syndromes and Genetic Testing 595
45 Hereditary Cancer Syndromes 597
Mary B. Daly
46 Hereditary Breast and Ovarian Cancer Syndromes 611
Kristen Whitaker and Elias Obeid
47 Hereditary Gastrointestinal and Pancreatic Cancer Syndromes 625
Kristen M. Shannon, Linda H. Rodgers-Fouche, and Daniel C. Chung
Part 10 Special Issues in Oncology 637
48 Cancer of Unknown Primary 639
Tony Greco
49 Anticoagulation in Cancer 651
Jean Marie Connors
50 Identification and Management of Immunotherapy-Related Adverse Events in Oncology 663
Ozge Gumusay, Laura A. Huppert, Dame Idossa, and Hope S. Rugo
51 Geriatric Oncology 677
Sukeshi Patel Arora and Efrat Dotan
52 Palliative Medicine for Curable and Terminal Cancers 693
Isabelle Blanchard, Kavitha Jennifer Ramachandran, and Divya Gupta
Index 709
Maurie Markman, MD, is President of Medicine & Science, Cancer Treatment Centers of America, Part of City of Hope.
Al B. Benson III, M.D FACP FASCO, is a Professor of Medicine in the Division of Hematology/Oncology at Northwestern University's Feinberg School of Medicine in Chicago, Illinois, and the Associate Director for Cooperative Groups at the Robert H. Lurie Comprehensive Cancer Center.
Hope S. Rugo, MD, FASCO, is Director of Breast Oncology and Clinical Trials Education and a Professor of Medicine at the University of California San Francisco Comprehensive Cancer Center.
